Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-423057

General Counsel and Secretary sold 1,040 shares at $49.26 ($51,230)

  • General Counsel and Secretary acquired 2,113 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KASINGER JAMES R. · General Counsel and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-13 Exercise or conversion : show line 1 in the form +2,113 96,897 D
2026-10-14 Sale : show line 2 in the form −1,040 $49.26 $51,230 95,857 D
Open-market sales · 1,040 sh · avg $49.26 · $51,230

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-13 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,113 0 D
Loading xslF345X06/ownership.xml…